Matthew Shea
Stock Analyst at Needham
(3.61)
# 2,181
Out of 5,076 analysts
43
Total ratings
55.2%
Success rate
12.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STLN Starling Oncology | Reiterated: Buy | $7 → $9 | $6.71 | +34.13% | 11 | Oct 14, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $41 | $37.45 | +9.48% | 4 | Aug 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $89.71 | - | 9 | Aug 6, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $4.80 | +4.17% | 12 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $22.41 | +33.87% | 7 | May 7, 2026 |
Starling Oncology
Oct 14, 2026
Reiterated: Buy
Price Target: $7 → $9
Current: $6.71
Upside: +34.13%
Astrana Health
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $37.45
Upside: +9.48%
agilon health
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $89.71
Upside: -
Evolent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $4.80
Upside: +4.17%
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $22.41
Upside: +33.87%